AI in Rare Disease Diagnostics Market Size, Share and Trends Analysis 2026 to 2035

Report Id: 3386 Pages: 180 Last Updated: 02 January 2026 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of AI in Rare Disease Diagnostics Market :

AI in Rare Disease Diagnostics Market by Component

  • Hardware
  • Software
  • Services

AI in Rare Disease Diagnostics Market

AI in Rare Disease Diagnostics Market by Deployment Mode

  • Cloud-based
  • On-premise

AI in Rare Disease Diagnostics Market by Technology

  • Computer Vision
  • Machine Learning
  • Natural Language Processing
  • Deep Learning
  • Others

AI in Rare Disease Diagnostics Market by Application

  • Metabolic Disorders
  • Genetic Disorders
  • Oncology Disorders
  • Neurological Disorders
  • Others

AI in Rare Disease Diagnostics Market by End-user

  • Hospitals
  • Research Institutes
  • Diagnostic Centers
  • Others

AI in Rare Disease Diagnostics Market-By Region

  • North America-
    • The US
    • Canada
  • Europe-
    • Germany
    • The UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific-
    • China
    • Japan
    • India
    • South Korea
    • South East Asia
    • Rest of Asia Pacific
  • Latin America-
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  •  Middle East & Africa-
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global `Snapshot

Chapter 4. Global AI in Rare Disease Diagnostics MarketVariables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends 
4.5. Investment and Funding Analysis 
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2035
4.8. Global AI in Rare Disease Diagnostics MarketPenetration & Growth Prospect Mapping (US$ Mn), 2025-2035
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2025)
4.10. Use/impact of AI on AI IN RARE DISEASE DIAGNOSTICS MARKETIndustry Trends 

Chapter 5. AI in Rare Disease Diagnostics MarketSegmentation 1: By Type of Component, Estimates & Trend Analysis
5.1. Market Share By Type of Component, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Type of Component:

5.2.1. Software
5.2.2. Hardware
5.2.3. Services

Chapter 6. AI in Rare Disease Diagnostics MarketSegmentation 2: By Type of Deployment Mode, Estimates & Trend Analysis
6.1. Market Share By Type of Deployment Mode, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Type of Deployment Mode:

6.2.1. Cloud-Based and On-Premises

Chapter 7. AI in Rare Disease Diagnostics MarketSegmentation 3: By Type of Technology, Estimates & Trend Analysis
7.1. Market Share By Type of Technology, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Type of Technology:

7.2.1. Machine Learning
7.2.2. Deep Learning
7.2.3. Natural Language Processing
7.2.4. Computer Vision
7.2.5. Others

Chapter 8. AI in Rare Disease Diagnostics MarketSegmentation 4: By Application Area, Estimates & Trend Analysis
8.1. Market Share By Application Area, 2025 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Type of Applicaion Area:

8.2.1. Genetic Disorders
8.2.2. Metabolic Disorders
8.2.3. Neurological Disorders
8.2.4. Oncology Disorders
8.2.5. Others

Chapter 9. AI in Rare Disease Diagnostics MarketSegmentation 5: By Type of End User, Estimates & Trend Analysis
9.1. Market Share By End User, 2025 & 2035
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Type of End User:

9.2.1. Hospitals
9.2.2. Diagonastic Center
9.2.3. Research Institutes
9.2.4. Others

Chapter 10. AI in Rare Disease Diagnostics MarketSegmentation 6: Regional Estimates & Trend Analysis
10.1. Global AI in Rare Disease Diagnostics Market, Regional Snapshot 2025 & 2035
10.2. North America

10.2.1. North America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts by Country, 2022-2035

10.2.1.1. US
10.2.1.2. Canada

10.2.2. North America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Component, 2022-2035
10.2.3. North America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Technology, 2022-2035
10.2.4. North America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Deployment Mode, 2022-2035
10.2.5. North America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Application Area, 2022-2035
10.2.6. North America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of End User, 2022-2035

10.3. Europe

10.3.1. Europe AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts by Country, 2022-2035

10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe

10.3.2. Europe AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Component, 2022-2035
10.3.3. Europe AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Technology, 2022-2035
10.3.4. Europe AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Deployment Mode, 2022-2035
10.3.5. Europe AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Application Area, 2022-2035
10.3.6. Europe AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of End User, 2022-2035

10.4. Asia Pacific

10.4.1. Asia Pacific AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts by Country, 2022-2035

10.4.1.1. India 
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific

10.4.2. Asia Pacific AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Component, 2022-2035
10.4.3. Asia Pacific AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Technology, 2022-2035
10.4.4. Asia Pacific AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Deployment Mode, 2022-2035
10.4.5. Asia Pacific AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Application Area, 2022-2035
10.4.6. Asia Pacific AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of End User, 2022-2035

10.5. Latin America

10.5.1. Latin America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts by Country, 2022-2035

10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America

10.5.2. Latin America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Component, 2022-2035
10.5.3. Latin America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Technology, 2022-2035
10.5.4. Latin America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Deployment Mode, 2022-2035
10.5.5. Latin America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Application Area, 2022-2035
10.5.6. Latin America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of End User, 2022-2035

10.6. Middle East & Africa

10.6.1. Middle East & Africa AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts by country, 2022-2035

10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa

10.6.2. Middle East & Africa AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Component, 2022-2035
10.6.3. Middle East & Africa AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Technology, 2022-2035
10.6.4. Middle East & Africa AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Deployment Mode, 2022-2035
10.6.5. Middle East & Africa AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Application Area, 2022-2035
10.6.6. Middle East & Africa AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of End User, 2022-2035

Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles

11.2.1. Bayer (Germany)

11.2.1.1. Business Overview
11.2.1.2. Key Product/Service 
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy

11.2.2.  BioMind (China)
11.2.3.  Congenica (UK)
11.2.4.  Deep Genomics (Canada)
11.2.5.  Enlitic (US)
11.2.6.  Face2Gene (US)
11.2.7.  Fabric Genomics (US)
11.2.8.  FDNA (US)
11.2.9.   Freenome (US)
11.2.10. GeneDx (US)
11.2.11. IBM Watson Health (US)
11.2.12. Invitae (US)
11.2.13. Mendel.ai (US)
11.2.14. Nostos Genomics (Germany)
11.2.15. PathAI (US)
11.2.16. PhenoTips (Canada)
11.2.17. Raremark (UK)
11.2.18. SOPHiA GENETICS (Switzerland)
11.2.19. Tempus Labs (US

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
6731
Security Code field cannot be blank!

Frequently Asked Questions

AI in Rare Disease Diagnostics Market Size is valued at USD 1.7 Bn in 2025 and is predicted to reach USD 19.4 Bn by the year 2035

AI in Rare Disease Diagnostics Market is expected to grow at a 28.7% CAGR during the forecast period for 2025 to 2034.

Deep Genomics, Bayer, Congenica, Enlitic, Face2Gene, BioMind, Fabric Genomics, FDNA, IBM Watson Health, Invitae, Freenome, GeneDx, Mendel.ai, Nostos Genomics, PathAI, SOPHiA GENETICS, Tempus Labs, PhenoTips, and Raremark

Component, Deployment Mode, Technology, Application and End-user are the key segments of the AI in Rare Disease Diagnostics Market.

North America region is leading the AI in Rare Disease Diagnostics Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying